Skip to main content
OpenTrials

Clinical trial condition

Myotonic Dystrophy Type 1

Explore clinical trials studying Myotonic Dystrophy Type 1. Study availability and eligibility vary by location and protocol.

17 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Myotonic Dystrophy Type 1 trial results

Completed

A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1

NCT02312011

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details
Completed

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

NCT00577577

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • University of California Irvine Medical Center; MDA, ALS and Neuromuscular Center Orange, California, United States
  • University of California, Davis Sacramento, California, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)

NCT02831504

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • Newcastle-upon-Tyne Hospitals NHS Trust Newcastle upon Tyne, Tyne and Wear, United Kingdom
  • University College London Hospitals NHS Foundation Trust, National Hospital for Neurology and Neurosurgery London, United Kingdom
View Trial Details
Completed

Multicenter Observational Study of Myotonic Dystrophy Type 1

NCT02308657

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • Stanford University Stanford, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • NIH Bethesda, Maryland, United States
View Trial Details
Completed

Observational Prolonged Trial in Myotonic Dystrophy Type 1

NCT02118779

Conditions
Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • Assistance Publique-Hospitaux de Paris Paris, France
  • Friedrich Naur Institute Munich, Germany
  • Radboud University Nijmegen Medical Centre Nijmegen, Netherlands
  • Newcastle University Newcastle, United Kingdom
View Trial Details

Related conditions